You searched for "globe"

1234 results found

CHEC and Royal National Institute for Blind People Launch Strategic Partnership

CHEC has today announced the launch of a new partnership with the Royal National Institute of Blind People.

CHEC ‘Re:Sets’ sights on patient outcomes and growth ambitions

CHEC, one of the largest providers of community-based ophthalmology services in the UK, has launched an enhanced go-to-market strategy that will better align its service offerings and provision with the NHS’ evolving needs.

RNIB focusing on supporting patients to ‘wait well’ at point of diagnosis this National Eye Health Week

To coincide with National Eye Health Week (18-24 September), the Royal National Institute of Blind People (RNIB) has launched a free guide bringing together information about services, tips for questions to ask when attending hospital appointments, and links to emotional support to help while you wait to find out more.

RNIB unveils Eye Care Support Pathway to transform eyecare support for patients

More than 100 people came together recently to back a new patient-centred approach to eyecare support. Royal National Institute of Blind People (RNIB) which has taken the lead on this work, hosted an event at Aston University in Birmingham on...

Know Your Risk: Glaucoma UK launches interactive online quiz to help prevent sight loss

Glaucoma is one of the leading causes of blindness in the UK – it can affect anyone, at any time, and is often symptomless. Approximately 700,000 people in the UK have glaucoma, but 50% of them don’t know - if...

Ocular Melanoma UK launches Ocular Melanoma October to shine a light on rare eye cancer

Ocular Melanoma UK (OMUK) the nation’s only charity dedicated exclusively to supporting those affected by ocular melanoma, today launched Ocular Melanoma October – a nationwide campaign highlighting the realities of living with this rare, life-threatening and often misunderstood cancer. Each...

A Shared Vision: national clinical director outlines plan for eye care transformation

This session will explore how nationally coordinated eye care can deliver improvements to patient outcomes, what should be the priorities and where responsibility for policy delivery sits across the NHS architecture. Attendees will have the opportunity to both learn more about NHS England’s ongoing work to support improvements to eye care and input into that process.

Isolated trochlear (fourth cranial) nerve palsy in an Asian population

The authors report on 35 consecutive new cases of isolated fourth cranial nerve palsy seen over a period of six months in one neuro-ophthalmology clinic in Southeast Asia, with emphasis on their aetiology and management. We report on 35 patients...

African-Caribbean ethnicity key risk factor for sight-threatening diabetic eye disease

People of African-Caribbean ethnicity with Type 2 diabetes are a third more likely to develop a condition called sight-threatening diabetic retinopathy (STDR) than other ethnic groups, according to researchers from King’s College London. The study, published in the journal Diabetes...

New Year’s Honours: Chair of Deafblind UK awarded OBE for services to people living with deafblindness

Deafblind UK has today welcomed the announcement that its Chair, Robert Nolan, has been awarded an OBE in the New Year’s Honours List for services to people living with deafblindness. Robert, who is deafblind himself and lives with Type 2...

National Usher Syndrome Helpline launched to provide one-stop support for people with Usher syndrome

Deafblind UK and Deafblind Scotland have announced the launch of a new Usher Syndrome Helpline, a dedicated national support service for people living with Usher syndrome and for families, carers and professionals supporting them. Launched by the charity partnership on...

Crystalline keratopathy in monoclonal gammopathy of undetermined significance

Monoclonal gammopathies encompass a group of plasma cell disorders characterised by the excessive production of abnormal monoclonal immunoglobulins in the bloodstream [1]. This category includes multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis and other lymphoproliferative disorders. Monoclonal gammopathy...